| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.005 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |